Aldeyra Therapeutics is a biotechnology company engaged in developing and commercializing medicines for patients with immune-mediated diseases. The company's primary product candidate, reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. The company has additional product candidates in development for proliferative vitreoretinopathy and other retinal diseases, autoimmune disease, and cancer. The company has discovered and are developing two additional reactive aldehyde species inhibitors, ADX-103 and ADX-629, for the treatment of retinal disease and autoimmune disease, respectively.

Amyris is an industrial biotechnology company that applies its technology platform to engineer, manufacture and sell products into the Health and Wellness, Clean Beauty, and Flavor and Fragrance markets. The company's technology platform enables it to engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into ingredients. The company is focused on the production of Biofene?, its brand of renewable farnesene, a long-chain, branched hydrocarbon molecule that it manufactures through fermentation using engineered microbes. The company's farnesene derivatives are sold in various products as nutrition, health, skincare, fragrances, solvents, and fragrance ingredients.

Pulse Biosciences is a bioelectric medicine company. The company is pursuing regulatory clearance to market CellFX? System (CellFX). The CellFX System utilizes its Nano-Pulse Stimulation? (NPS) technology to treat various applications for which an optimal solution remains unfulfilled. NPS is a proprietary technology that delivers nanosecond duration pulses of high amplitude electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue. The company's CellFX System allows for the adjustment of four key treatment parameters: pulse duration, pulse amplitude, pulse frequency, and the number of pulses, depending on the target tissue, application and desired treatment outcome.

ServiceSource International is engaged in outsourced customer success and revenue growth solutions. The company's solutions span the lifecycle of its clients' customers, from landing new customers (Co. provides lead generation, inside sales, and outsourced sales operations services), adoption (Co. provides customer onboarding and customer success management services), expansion (Co. provides cross-sell and upsell, warranty conversion, account-based marketing and channel recruitment and enablement) and renewals (Co. provides renewals management services, including the sale of maintenance and support service contracts for the products used by its clients' end-users).